Senseonics Holdings, Inc. Common Stock (SENS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $579.58M
Last updated: Nov 17, 2026 at 11:05 AM ET
Senseonics Holdings, Inc. Common Stock (SENS) Financials: Revenue, Profit and Cash Flow
Senseonics Holdings, Inc. Common Stock reported revenue of $35.26M for the fiscal year ended Dec 31, 2025, up 56.9% from the year before. That year, net income was -$69.11M with a net margin of -196.0%, operating cash flow was -$59.13M and free cash flow was -$60.24M. The quarter ended Sep 30, 2026 had revenue of $19.56M and net income of -$32.68M.
Revenue and Margins
Over the 9 years to Dec 2025, revenue grew from $332.00K, a compound annual rate of 67.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $35.26M | +56.9% | 44.7% | -193.8% | -196.0% |
| Dec 2024 | $22.47M | +0.4% | 2.4% | -333.0% | -349.8% |
| Dec 2023 | $22.39M | +36.6% | 13.8% | -337.7% | -269.7% |
| Dec 2022 | $16.39M | +19.8% | 16.6% | -418.7% | 867.2% |
| Dec 2021 | $13.68M | +176.3% | -5.9% | -418.1% | -2211.9% |
| Dec 2020 | $4.95M | -76.8% | -350.9% | -1598.9% | -3539.5% |
| Dec 2019 | $21.30M | +12.6% | -91.3% | -613.4% | -542.5% |
| Dec 2018 | $18.91M | +196.8% | -43.1% | -463.1% | -496.9% |
| Dec 2017 | $6.37M | +1819.6% | -53.1% | -883.6% | -927.4% |
| Dec 2016 | $332.00K | N/A | -98.8% | -12781.0% | -13231.9% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $35.26M | $22.47M | $22.39M | $16.39M | $13.68M | $4.95M | $21.30M | $18.91M | $6.37M | $332.00K |
| Cost of revenue | $19.49M | $21.94M | $19.30M | $13.66M | $14.49M | $22.32M | $40.75M | $27.06M | $9.76M | $660.00K |
| Gross profit | $15.76M | $533.00K | $3.09M | $2.73M | -$811.00K | -$17.37M | -$19.45M | -$8.15M | -$3.38M | -$328.00K |
| Research and development | $31.59M | $41.14M | $48.75M | $39.72M | $27.22M | $20.41M | $38.43M | $31.86M | $30.73M | $26.35M |
| Operating income | -$68.34M | -$74.84M | -$75.60M | -$68.63M | -$57.18M | -$79.13M | -$130.66M | -$87.58M | -$56.31M | -$42.43M |
| Net income | -$69.11M | -$78.62M | -$60.39M | $142.12M | -$302.47M | -$175.17M | -$115.55M | -$93.97M | -$59.10M | -$43.93M |
| EBITDA | -$68.27M | -$74.53M | -$56.03M | $160.08M | N/A | N/A | -$101.34M | -$87.42M | -$55.46M | -$42.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.56M | $14.48M | $11.71M | $14.26M | $8.10M | $6.65M | $6.26M | $8.30M | $4.26M | $4.87M | $5.05M | $8.03M |
| Gross profit | $12.07M | $8.56M | $6.94M | $7.67M | $3.47M | $3.12M | $1.50M | $3.95M | -$4.05M | $298.00K | $335.00K | $1.09M |
| Operating income | -$31.86M | -$35.99M | -$31.85M | -$20.93M | -$19.60M | -$14.32M | -$13.49M | -$14.27M | -$22.85M | -$19.49M | -$18.23M | -$17.00M |
| Net income | -$32.68M | -$36.70M | -$32.33M | -$20.82M | -$19.53M | -$14.50M | -$14.26M | -$15.48M | -$23.98M | -$20.29M | -$18.88M | -$17.19M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $35.59M by $4.65M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $126.27M | $100.44M | $138.22M | $177.67M | $198.93M | $35.92M | $132.80M | $159.97M | $45.94M | $22.27M |
| Current assets | $117.53M | $91.44M | $130.03M | $161.20M | $144.41M | $30.25M | $127.76M | $158.11M | $44.91M | $21.43M |
| Cash and equivalents | $40.23M | $74.60M | $75.71M | $35.79M | $33.46M | $18.00M | $95.94M | $136.79M | $16.15M | $13.05M |
| Total liabilities | $65.22M | $79.34M | $64.77M | $142.59M | $384.46M | $177.19M | $141.45M | $88.71M | $38.68M | $27.15M |
| Short-term debt | $0 | $20.14M | $0 | $15.58M | $2.93M | $3.20M | $103.79M | $10.00M | $10.00M | $3.89M |
| Long-term debt | $35.59M | $34.70M | $41.20M | $56.38M | $59.80M | $57.22M | $11.80M | $57.98M | $14.41M | $15.18M |
| Shareholder equity | $61.05M | -$16.55M | $35.80M | -$2.58M | -$185.53M | -$144.08M | -$8.65M | $71.26M | $7.27M | -$4.88M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $162.51M | $176.84M | $102.86M | $126.27M | $139.92M | $150.27M | $87.21M | $100.44M | $96.33M | $111.56M | $126.52M | $138.22M |
| Total liabilities | $84.89M | $86.52M | $68.52M | $65.22M | $61.76M | $55.55M | $52.01M | $116.99M | $75.86M | $73.33M | $69.90M | $102.42M |
| Cash and equivalents | $47.76M | $44.75M | $29.61M | $40.55M | $34.46M | $31.52M | $39.31M | $74.60M | $27.11M | $34.85M | $90.54M | $75.71M |
| Shareholder equity | $77.62M | $90.31M | $34.34M | $61.05M | $78.17M | $94.72M | $35.20M | -$16.55M | -$17.18M | $578.00K | $18.96M | $35.80M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$59.13M | -$60.47M | -$70.16M | -$66.31M | -$56.08M | -$67.42M | -$136.05M | -$90.77M | -$55.74M | -$38.02M |
| Capital expenditures | $1.12M | $2.24M | $350.00K | $312.00K | $210.00K | $181.00K | $1.04M | $989.00K | $345.00K | $479.00K |
| Free cash flow | -$60.24M | -$62.70M | -$70.51M | -$66.62M | -$56.29M | -$67.60M | -$137.09M | -$91.76M | -$56.08M | -$38.49M |
| Dividends paid | N/A | N/A | N/A | $2.57M | $5.29M | $550.00K | N/A | N/A | N/A | N/A |
| Share repurchases | N/A | N/A | N/A | N/A | N/A | N/A | $2.05M | $0 | $695.00K | $447.00K |
| Investing cash flow | -$53.42M | $32.84M | $89.71M | $26.88M | -$148.75M | -$181.00K | -$1.04M | $19.43M | -$13.23M | -$7.77M |
| Financing cash flow | $78.19M | $26.83M | $20.37M | $41.76M | $220.08M | -$10.13M | $96.24M | $191.99M | $72.07M | $54.89M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$32.94M | -$30.14M | -$32.02M | -$17.96M | -$15.82M | -$9.27M | -$16.08M | -$14.25M | -$14.81M | -$11.14M | -$20.26M | -$15.07M |
| Capital expenditures | $235.00K | $217.00K | $111.00K | $394.00K | $164.00K | $124.00K | $434.00K | $34.00K | $203.00K | $2.09M | $316.00K | $170.00K |
| Free cash flow | -$33.17M | -$30.36M | -$32.14M | -$18.36M | -$15.98M | -$9.39M | -$16.51M | -$14.28M | -$15.02M | -$13.23M | -$20.58M | -$15.24M |
Frequently Asked Questions About SENS
What is Senseonics Holdings, Inc. Common Stock's annual revenue?
Senseonics Holdings, Inc. Common Stock reported revenue of $35.26M for the fiscal year ended Dec 31, 2025.
How fast is Senseonics Holdings, Inc. Common Stock's revenue growing?
Revenue was up 56.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 29.1%.
Is Senseonics Holdings, Inc. Common Stock profitable?
No. Senseonics Holdings, Inc. Common Stock reported net income of -$69.11M for the fiscal year ended Dec 31, 2025, with a net margin of -196.0%.
How much free cash flow does SENS generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$59.13M minus capital expenditures of $1.12M produced free cash flow of -$60.24M.
How much debt does Senseonics Holdings, Inc. Common Stock have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $35.59M, short-term debt of $0 and cash and equivalents of $40.23M.
SENS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors